CCL2 and familial dilated cardiomyopathy: Using Fluorescence imaging to quantity the MSCs that engraftment into the heart, we found that CCR2 inhibition significantly decreased the amount of MSCs that migrated to the myocardial in DCM (Figure 6B,C), indicating that MCP-1/CCR2 signaling is required for MSCs homing in DCM.